Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Aspirin, Dipyridamole Drug Combination MeSH Descriptor Data 2026


MeSH Heading
Aspirin, Dipyridamole Drug Combination
Tree Number(s)
D02.455.426.559.389.657.410.595.176.500
D03.383.742.175.500
D26.310.125
Unique ID
D000068342
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068342
Scope Note
A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.
Entry Term(s)
Aggrenox
Asasantin
Asasantin Retard
Aspirin-Dipyridamole Drug Combination
Extended-Release Dipyridamole-Aspirin
TX 3301
TX-3301
Pharm Action
Platelet Aggregation Inhibitors
Registry Numbers
0
Public MeSH Note
2016; ASPIRIN-DIPYRIDAMOLE DRUG COMBINATION was indexed under ASPIRIN and DIPYRIDAMOLE 1986-2015
History Note
2016 (1986)
Date Introduced
2016/01/01
Last Updated
2016/05/27
Aspirin, Dipyridamole Drug Combination Preferred
Asasantin Narrower
TX 3301 Narrower
Aggrenox Narrower
Extended-Release Dipyridamole-Aspirin Narrower
Asasantin Retard Narrower
page delivered in 0.133s